CNS innovator oligonucleotide licensing value surges by 339% to $2.8 billion in 2024, reveals… EP News Bureau Jun 24, 2025 GlobalData attributes surge in CNS oligonucleotide licensing to increased adoption of ASOs and siRNAs, alongside advancements in…
Angelini Pharma acquires Arvelle Therapeutics for $960 million EP News Bureau Jan 4, 2021 Angelini Pharma will have the exclusive license to commercialise cenobamate in the European Union and other countries in the…
